OPCML
Opioid-binding protein/cell adhesion molecule
Also known as: IGLON1, OBCAM, OPCM, OPCM_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14982
- Gene
- OPCML
- Ensembl
- ENSG00000183715
- Chromosome
- 11
- Canonical length
- 345 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes a member of the IgLON subfamily in the immunoglobulin protein superfamily of proteins. The encoded preprotein is proteolytically processed to generate the mature protein. This protein is localized in the plasma membrane and may have an accessory role in opioid receptor function. This gene has an ortholog in rat and bovine. The opioid binding-cell adhesion molecule encoded by the rat gene binds opioid alkaloids in the presence of acidic lipids, exhibits selectivity for mu ligands and acts as a GPI-anchored protein. Since the encoded protein is highly conserved in species during evolution, it may have a fundamental role in mammalian systems. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]
Canonical amino-acid sequenceUniProt
345 residues, UniProt reviewed canonical sequence.
>Q14982|OPCML
1 MGVCGYLFLP WKCLVVVSLR LLFLVPTGVP VRSGDATFPK AMDNVTVRQG ESATLRCTID
61 DRVTRVAWLN RSTILYAGND KWSIDPRVII LVNTPTQYSI MIQNVDVYDE GPYTCSVQTD
121 NHPKTSRVHL IVQVPPQIMN ISSDITVNEG SSVTLLCLAI GRPEPTVTWR HLSVKEGQGF
181 VSEDEYLEIS DIKRDQSGEY ECSALNDVAA PDVRKVKITV NYPPYISKAK NTGVSVGQKG
241 ILSCEASAVP MAEFQWFKEE TRLATGLDGM RIENKGRMST LTFFNVSEKD YGNYTCVATN
301 KLGNTNASIT LYGPGAVIDG VNSASRALAC LWLSGTLLAH FFIKFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OPCML can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 35 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 35 nTPM
- cerebellum: 22 nTPM
- retina: 11 nTPM
- parathyroid gland: 9.7 nTPM
- hippocampal formation: 6.8 nTPM
- amygdala: 4.6 nTPM
Single-cell type
- oligodendrocyte progenitor cells: 5,525 nCPM
- brain excitatory neurons: 2,290 nCPM
- corticotrophs: 2,235 nCPM
- retinal pigment epithelial cells: 2,068 nCPM
- brain inhibitory neurons: 1,695 nCPM
- other brain neurons: 1,160 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 117 nTPM
- cerebellum: 83 nTPM
- white matter: 64 nTPM
- basal ganglia: 63 nTPM
- hippocampal formation: 60 nTPM
- thalamus: 52 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about OPCML.
Disease | AllUniProt
Conditions OPCML is implicated in, by any mechanism.
- Ovarian cancer (OC) MIM:167000
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 48 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.57
- gnomAD pLI
- 0.23
- gnomAD missense Z
- 1.82
- DepMap mean gene effect
- 0.2
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OPCML as an antibody target. Whether an autoantibody or antibody against OPCML could matter depends on whether native OPCML is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OPCML is annotated at the cell surface, where native OPCML is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label OPCML as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...